President Elect - David Cipolla

President Elect

David Cipolla, PhD (USA)

David Cipolla is an accomplished pharmaceutical and biotechnology professional with 30 years of diverse inhalation experience spanning a breadth of focus including preclinical research, formulation and analytical development, and delivery of APIs ranging from small molecules to peptides, proteins, antibodies, nucleic acids and including combination products. David is currently the VP of Research at Insmed Incorporated, where he is part of a team developing novel, targeted therapies to help serve the critical unmet needs of patients battling serious rare diseases.

Prior to joining Insmed in 2018, David worked at Aradigm (1996 to 2018) covering all phases of product development and led the development of preclinical research, CMC activities and intellectual property. Prior to joining Aradigm, David worked at Genentech, Inc. (1988 to 1996) developing and characterizing the delivery of protein aerosols to the airways, culminating with the approval of Pulmozyme® rhDNase for the management of cystic fibrosis in 1993. David holds a chemical engineering degree from MIT (SB) and UC Davis (MS) and a pharmacy degree from the University of Sydney (PhD).

David has demonstrated a sustained commitment to ISAM over a twenty-year period serving first as a Comptroller (2001-2009), co-organizing the 2009 ISAM Congress in Monterey, serving on the scientific organizing committees of the ISAM Congresses in 2011, 2013, 2015, 2019, 2021 and 2023, serving as chair or co-chair of the ISAM Regulatory Affairs Working Group (2009-2011; 2017-2023) and serving on the Board of Directors (2011-2013 and 2013-2015).

Additionally, outreach to other scientific communities including IPAC-RS, Inhalation Asia, and more recently AAPS has led to collaborations in numerous workshops and conferences over the past decade. David was also a board member of IPAC-RS from 2002-2008 and served as Vice Chair (2004- 2006) and Chair (2006-2008). David recently received the 2022 Thomas T. Mercer Award in recognition for his career in the inhalation field.